Testing immune cells engineered to fight aggressive brain tumors

This trial is testing a new treatment called 4sCAR-DLL3 CAR-T therapy, which works by taking your own immune cells, training them in a laboratory to recognize and attack brain tumor cells, and then putting them back into your body. The treatment targets a specific protein found on brain tumors called DLL3, which is rarely found on healthy cells. Researchers believe this targeted approach could offer hope for patients whose brain tumors have come back or stopped responding to standard treatments like surgery, radiation, and chemotherapy.

Aggressive brain tumors like glioblastoma have very few treatment options and very poor survival rates, especially when they return or resist standard care. This medication represents a new approach that harnesses your own immune system to fight these hard-to-treat cancers in a more precise way.